Beta Bionics, Inc. (BBNX) Receivables (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Receivables data on file, last reported at $15.8 million in Q1 2026.

• Quarterly Receivables rose 73.84% year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (up 73.84% YoY) and the FY2025 annual result came in at $17.3 million, up 44.0% from the prior year.
• Receivables retreated to $15.8 million in Q1 2026 per BBNX's latest filing, from $17.3 million in the prior quarter.
• The five-year high for Receivables was $17.3 million in Q4 2025, with the low at $4.4 million in Q4 2023.
• Average Receivables over 4 years is $11.7 million, with a median of $11.7 million recorded in 2025.
• Year-over-year, Receivables soared 169.69% in 2024 and surged 44.0% in 2025.
• Beta Bionics' Receivables stood at $4.4 million in 2023, then soared by 169.69% to $12.0 million in 2024, then surged by 44.0% to $17.3 million in 2025, then declined by 8.82% to $15.8 million in 2026.
• Business Quant data shows BBNX's Receivables at $15.8 million in Q1 2026, $17.3 million in Q4 2025, and $11.7 million in Q3 2025.